Italy High-Throughput Screening (HTS) Market (2026-2031)
The Italy High-Throughput Screening (HTS) Market was valued at $431 Million in 2026 and projected to reach to $554.3 Million by 2031, representing a compound annual growth rate of 8.7%. Italy's High-Throughput Screening market is positioned for steady growth through 2031, driven by increased pharmaceutical R&D spending and the modernization of research infrastructure across Italian biotech companies and academic centers.
Italy High-Throughput Screening (HTS) Market Trends and Insights
- Spain's HTS sector is benefiting from increased pharmaceutical R&D investment and the adoption of automation technologies across Spanish research institutions and biotech companies.
- The market in Spain reflects broader European trends toward accelerated drug discovery and personalized medicine, with Spanish laboratories increasingly integrating HTS platforms to enhance screening efficiency and reduce time-to-market for novel therapeutics. Spain's HTS market growth is driven by rising demand for cost-effective screening solutions and the expansion of contract research organizations (CROs) operating within the country.
- Spain's position within the European Union supports access to collaborative research networks and funding mechanisms that facilitate HTS adoption.
- Between 2026 and 2031, Spain is expected to see steady market expansion as pharmaceutical companies and academic institutions invest in high-throughput technologies to support genomics, proteomics, and drug candidate validation..
Key Market Statistics
- CAGR (2026-2031) 8.7% CAGR
- Market Size, 2026 ~USD 431 Million
- Forecast, 2031 ~USD 554.3 Million
- Country Italy
Italy High-Throughput Screening (HTS) Market Overview
Market Size & Growth :
Italy's High-Throughput Screening market is valued at USD 431.0 million in 2026 and is projected to reach USD 554.3 million by 2031, with a CAGR of 8.7%, outpacing several European peers.
Pharmaceutical R&D Investment :
Italian pharmaceutical companies and research institutions are increasingly investing in HTS technologies to accelerate drug discovery and development, driven by competitive pressures and innovation mandates.
Automation & Technology Adoption :
Italian biotech firms and CROs are rapidly adopting automated screening platforms and robotics to improve throughput, reduce costs, and enhance data quality in preclinical research workflows.
Regional Research Hub Growth :
Italy's established life sciences clusters in Milan, Rome, and Bologna are fostering collaboration between academic institutions and industry, accelerating HTS market expansion and technology transfer.
Italy High-Throughput Screening (HTS) Market Dynamics
- The adoption of advanced automation technologies and integration of artificial intelligence in screening workflows are expected to enhance operational efficiency and reduce time-to-market for new therapeutics. Government support for life sciences innovation and EU funding initiatives are further catalyzing market expansion.
- Italian CROs and contract research organizations are investing in state-of-the-art HTS capabilities to serve both domestic and international pharmaceutical clients, strengthening Italy's position as a competitive research destination in Europe..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Spain's HTS market is valued at USD 431.0 million in 2026 and will reach USD 554.3 million by 2031, growing at 8.7% CAGR.
- Spain's pharmaceutical and biotech sectors are increasingly adopting HTS platforms to accelerate drug discovery and reduce development timelines.
- Spain's EU membership provides access to collaborative research networks and funding that support HTS technology adoption and market growth.
- Spain's CRO expansion and rising R&D investments are key drivers of HTS market expansion through 2031.
High-Throughput Screening (HTS) Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | LIQUID HANDLING SYSTEMS (Application) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.7% from 2026 to 2031 |
| Largest Segment | NORTH AMERICA (Type) |
| Market Size Base Year (Billions) | ~USD 27.61 (2026) |
| Revenue Forecast (Billions) | ~USD 45.9 (2031) |
| Segments Covered | Type, Application, Technology |
Italy High-Throughput Screening (HTS) Market Report Segmentation
3 segment dimensions are covered across the global market.
By Type
- 2D Cell Cultures
- 3D Cell Cultures
- Alginate/Agarose
- Animal-Derived Hydrogels
- Collagen
- Detection Systems
- Hydrogels
- Imaging Instruments
- Inert Matrix/Solid Scaffolds
- Laboratory Consumables
- Liquid Handling Systems
- Matrigel
- Micropatterned Surfaces
- Other Instruments
- Perfusion Cell Cultures
- Reagents & Assay Kits
- Reporter-Based Assays
- Scaffold-Based Technology
- Scaffold-Free Technology
- Synthetic Hydrogels
By Application
- Biochemical Screening
- Drug Discovery
- Life Science Research
- Other Applications
By Technology
- Cell-Based Assays
- Lab-On-A-Chip
- Label-Free Technology
Target Audience
- Pharmaceutical Companies : Italian and international pharma firms need Italy-specific HTS market data to optimize R&D investments, evaluate local CRO partnerships, and plan drug discovery initiatives in Italy.
- Biotech & CRO Executives : Italian biotech companies and contract research organizations require detailed market insights to benchmark performance, identify growth opportunities, and make informed technology investments.
- Technology & Equipment Vendors : HTS equipment manufacturers and software providers need Italy market intelligence to assess demand, identify customer segments, and develop localized go-to-market strategies.
- Investment & Private Equity Firms : Investors evaluating opportunities in Italian life sciences need comprehensive market data to assess growth potential, competitive dynamics, and valuation benchmarks for HTS-related companies.
- Government & Policy Makers : Italian government agencies and research institutions require market insights to inform innovation policy, funding allocation, and strategic initiatives supporting the HTS and life sciences sector.
Key Companies in the Italy High-Throughput Screening (HTS) Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOCARTIS SA | Belgium | Private Company | Oncology assay consumables,Instrument systems and service,Other legacy and residual activities, |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Molecular diagnostics assays (TB, oncology, sexual and reproductive health, viral load),PCR and enzyme solutions (qPCR, dPCR, RT-PCR, configured enzymes), |
| CODEXIS, INC. | United States | Public Company | CodeEvolver platform-enabled enzyme sales and services,ECO Synthesis platform for RNAi and nucleic acid manufacturing,Licensing and royalties from technology partnerships, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing, single-use, filtration, aseptic fill-finish),Life Sciences (analytical instruments, genomics, lab automation),Diagnostics (clinical instruments, consumables, software, services), |
| MERCK KGAA | Germany | Public Company | Life Science,Healthcare,Electronics, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| REVVITY, INC. | United States | Public Company | Diagnostics (prenatal, neonatal, infectious disease, immunodiagnostics),Life science reagents and assays (BioLegend, Dharmacon, Alpha platforms),Instruments and imaging systems, |
| TECAN GROUP LTD. | Switzerland | Public Company | Liquid handling and automation platforms (incl. Tecan Labwerx),Microplate readers, washers, and detection instruments,Consumables, sequencing reagents, immunoassays, and antibodies, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics systems, kits, and quality controls,Life Science instruments and reagents,Informatics and software, |
| CORNING INCORPORATED | United States | Public Company | Optical communications (fiber, cable, hardware, connectivity),Display glass substrates (LCD and OLED),Specialty materials and mobile consumer electronics glass, |
| METTLER-TOLEDO INTERNATIONAL INC. | Switzerland | Public Company | Laboratory instruments and LabX software,Industrial instruments and product inspection,Retail weighing and fresh-goods solutions, |
| LONZA GROUP | Switzerland | Public Company | Integrated Biologics,Advanced Synthesis (small molecules, ADCs, HPAPIs),Specialized Modalities (cell & gene, microbial, bioscience, mRNA), |
| WATERS CORPORATION | United States | Public Company | Liquid Chromatography Systems and Columns,Mass Spectrometry Systems,TA Instruments (Thermal, Rheometry, Calorimetry), |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, filtration, chromatography, fluid management),Lab products and services (weighing, pipettes, filtration, microbiological testing),Advanced analytical and cell analysis systems (BLI, SPR, cytometry, live-cell imaging), |
| EPPENDORF SE | Germany | Private Company | Liquid handling (pipettes, dispensers, automated systems),Separation & instrumentation (centrifuges, PCR cyclers, ULT freezers),Consumables (tubes, tips, plates, single-use bioreactors), |
| PORVAIR PLC | United Kingdom | Public Company | Aerospace & Industrial Filtration,Laboratory Instruments and Consumables,Metal Melt Quality (Porous Ceramic Filters), |
BIOCARTIS SA
BIOCARTIS SA is a Belgian private company established in 2014 with 500 employees. The company focuses on molecular diagnostics and personalized medicine solutions.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company is a leading provider of molecular diagnostics, sample preparation, and life sciences research tools.
CODEXIS, INC.
CODEXIS, INC. is a United States public company founded in 2002 with 146 employees. The company develops enzyme engineering and biocatalysis solutions for pharmaceutical and industrial applications.
THERMO FISHER SCIENTIFIC INC.
THERMO FISHER SCIENTIFIC INC. is a United States public company founded in 1956 with 125,000 employees. The company is a global leader in serving science with a broad portfolio of laboratory equipment, reagents, and services.
DANAHER CORPORATION
DANAHER CORPORATION is a United States public company founded in 1969 with 59,000 employees. The company operates a diversified conglomerate with significant presence in life sciences, diagnostics, and environmental solutions.
MERCK KGAA
MERCK KGAA is a German public company founded in 1668 with 59,077 employees. The company is a global science and technology leader operating in pharmaceuticals, life sciences, and performance materials.
AGILENT TECHNOLOGIES, INC.
AGILENT TECHNOLOGIES, INC. is a United States public company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences, diagnostics, and applied chemical markets.
REVVITY, INC.
REVVITY, INC. is a United States public company founded in 1937 with 11,000 employees. The company develops and manufactures analytical instruments and software for life sciences research and diagnostics.
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss public company founded in 1980 with 3,166 employees. The company specializes in laboratory automation and detection solutions for life sciences and diagnostics applications.
BIO-RAD LABORATORIES, INC.
BIO-RAD LABORATORIES, INC. is a United States public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research products and clinical diagnostics solutions.
CORNING INCORPORATED
CORNING INCORPORATED is a United States public company founded in 1851 with 67,200 employees. The company is a diversified technology leader with significant operations in life sciences, laboratory products, and specialty materials.
METTLER-TOLEDO INTERNATIONAL INC.
METTLER-TOLEDO INTERNATIONAL INC. is a Swiss public company founded in 1991 with 16,600 employees. The company manufactures precision instruments and services for laboratory, industrial, and retail applications.
LONZA GROUP
LONZA GROUP is a Swiss public company founded in 1897 with 20,000 employees. The company is a leading supplier of products and services for the pharmaceutical, biotech, and specialty chemical industries.
WATERS CORPORATION
WATERS CORPORATION is a United States public company founded in 1958 with 7,900 employees. The company develops and manufactures analytical instruments and software for laboratory and life sciences applications.
SARTORIUS AG
SARTORIUS AG is a German public company founded in 1870 with 14,242 employees. The company provides laboratory and process technologies for pharmaceutical, biotech, and food industries.
EPPENDORF SE
EPPENDORF SE is a German private company founded in 1945 with 4,358 employees. The company manufactures laboratory equipment and consumables for life sciences research and diagnostics.
PORVAIR PLC
PORVAIR PLC is a United Kingdom public company founded in 1982 with 992 employees. The company manufactures advanced filtration and separation products for life sciences and industrial applications.
Reasons to Buy this Report
- Italy-Specific Market Sizing : Obtain precise market valuation and forecasts tailored to Italy's HTS sector, enabling accurate budgeting and investment decisions for operations in this key European market.
- Competitive Landscape Intelligence : Understand the competitive positioning of Italian HTS providers, CROs, and technology vendors to identify partnership opportunities and market entry strategies.
- Growth Driver Analysis : Identify key drivers of Italy's 8.7% CAGR growth, including pharmaceutical R&D trends, automation adoption rates, and regulatory factors specific to the Italian market.
- Regional Investment Opportunities : Discover high-potential investment targets and expansion opportunities within Italy's life sciences clusters and emerging biotech hubs.
- Strategic Planning & Forecasting : Leverage Italy-focused market projections through 2031 to develop long-term business strategies, product roadmaps, and market penetration plans for the Italian HTS sector.
Frequently asked questions
What is the current size of Spain's HTS market?
Spain's High-Throughput Screening market is valued at USD 431.0 million in 2026.
What is the projected size of Spain's HTS market by 2031?
Spain's HTS market is projected to reach USD 554.3 million by 2031.
What is the CAGR for Spain's HTS market?
Spain's HTS market is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.
What are the main drivers of HTS market growth in Spain?
Key drivers include increased pharmaceutical R&D investment, adoption of automation technologies, expansion of CROs, and Spain's access to EU research networks and funding mechanisms.
How does Spain's HTS market compare to the global market?
Spain's HTS market CAGR of 8.7% is slightly below the global CAGR of 10.7%, reflecting regional market maturity and competitive dynamics within Europe.
RESEARCH METHODOLOGY
This research study relied heavily on secondary sources, directories, and databases to identify and collect valuable information for analyzing the global high-throughput screening (HTS) market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the high-throughput screening (HTS) market. The secondary sources used for this study include World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), National Center for Advancing Translational Sciences (NCATS), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Health Service (NHS), Pharmaceuticals and Medical Devices Agency (PMDA), European Medicines Agency (EMA), Society for Laboratory Automation and Screening (SLAS), European Bioinformatics Institute, and Center for Translational Research, among others. Corporate filings include annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data were collected and analyzed to determine the overall size of the global high-throughput screening (HTS) market, which was subsequently validated through primary research. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were employed to estimate and validate the overall size of the high-throughput screening (HTS) market. These methods were also widely used to determine the size of various market segments. The research methodology used to estimate the market size includes the following:
High-Throughput Screening (HTS) Market : Top-Down and Bottom-Up Approach
Data Triangulation
After estimating the overall market size, the total market was divided into segments and subsegments. Data triangulation and market breakdown techniques were used where applicable to finalize the overall market analysis and obtain precise statistics for all segments and subsegments. The data was triangulated by examining various factors and trends from both demand and supply sides.
Market Definition
High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays.
The HTS market comprises products (instruments, reagents & consumables, software), and services used to perform automated, parallel screening of large compound or biological libraries against defined biological targets or assays to identify active entities (hits). The high-throughput screening (HTS) market comprises workflow stages from assay development and compound library management to automated large-scale screening and hit identification, culminating in validated screening hits.
Key Stakeholders
- Contract research organizations
- Pharmaceutical & biopharmaceutical companies
- Academic & research institutes
- High-throughput screening instrument & reagent manufacturers
- High-content screening database, service, and software providers
- Venture capitalists & investors
- Market research & consulting firms
- Government associations
- Medical institutions & universities
Report Objectives
- To define, describe, and forecast the high-throughput screening (HTS) market by offering, products by type, products by technology, products by workflow, products by end user, services by type, services by end user, application, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall high-throughput screening (HTS) market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players and analyze their market shares and core competencies2
- To track and analyze competitive developments, such as product & service launches, agreements, partnerships, acquisitions, and research & development activities
- To analyze and provide funding & investment activities, brand/product/service comparative analysis, and vendor valuation & financial metrics of the high-throughput screening (HTS) market
Customization Options
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product/Service Matrix gives a detailed comparison of the product/service portfolios of the top five companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- Further breakdown of the Rest of Europe high-throughput screening (HTS) market, by country
- Further breakdown of the Rest of Asia Pacific high-throughput screening (HTS) market, by country
- Further breakdown of the Rest of Latin America high-throughput screening (HTS) market, by country
Get the Full High-Throughput Screening (HTS) Market Report
Full forecast, segment splits, and company analysis for all High-Throughput Screening (HTS) Market.
- Canada High-Throughput Screening (HTS) Market
- US High-Throughput Screening (HTS) Market
- Germany High-Throughput Screening (HTS) Market
- UK High-Throughput Screening (HTS) Market
- France High-Throughput Screening (HTS) Market
- Spain High-Throughput Screening (HTS) Market
- China High-Throughput Screening (HTS) Market
- Japan High-Throughput Screening (HTS) Market
- India High-Throughput Screening (HTS) Market
- Australia High-Throughput Screening (HTS) Market
- South Korea High-Throughput Screening (HTS) Market
- Brazil High-Throughput Screening (HTS) Market
- Mexico High-Throughput Screening (HTS) Market
- Saudi Arabia High-Throughput Screening (HTS) Market
- UAE High-Throughput Screening (HTS) Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report